Bangladesh: Vaccines, Therapeutics, and Diagnostics Manufacturing and Regulatory Strengthening Project
The project will establish a vaccine, therapeutic, and diagnostics manufacturing facility and warehousing unit in Essential Drugs Company Limited's (EDCL) existing location at Gopalganj, with a capacity to manufacture 58 million vials of vaccines per year. An in-house research and development center will be established to support the production of diagnostic kits and packaging of biosimilar therapeutics. It will also support the manufacture of at least two full-cycle vaccines by developing a seed bank, master cell bank, and working cell bank, in addition to at least five fill-and-finish vaccines.
| PROJECT DETAILS | ||
|
Commitment Date Funding Type Country Sector Status Total Cost |
28 Nov 2023 Loan Bangladesh Health Ongoing $389.01 million | |
| KEY OUTPUTS |
Established manufacturing facility for vaccines, therapeutics, and diagnostics Established capacity for vaccines, therapeutics, and diagnostics manufacturing Strengthened capacity of the Directorate General of Drug Administration to regulate vaccines, therapeutics, and diagnostics |
| FINANCING |
$168.25 million (Asian Development Fund / Concessional ordinary capital resources lending) $168.22 million (Asian Development Bank Ordinary Capital Resources) $52.54 million (Government of Bangladesh) |
